Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > How long?
View:
Post by Kusanation on Nov 25, 2020 5:15pm

How long?

In the news release today it stated that Sona has  "to obtain more clinical data to augment its submission." The questions I have are (and hopefully you can help me answer them):

1) does this mean Sona needs to do further testing? or do they just need to adjust their application?

2) how long will this typically take until they re-submit? Is it a quick turn around? (seemed like it might be through the way things were worded by Darren in the press release) or will such an adjustment take a long time? 


If your going to troll, not the time.

Comment by Waco4505 on Nov 25, 2020 5:28pm
I have s response from David Regan via email  The company has what we believe is a great test that has not yet secured regulatory approval.  It has great underlying technology that can be applied to many tests in the future.  
Comment by burnout29 on Nov 25, 2020 5:44pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities